Emerging opportunities include advancements in mRNA and viral vector technologies for rapid development, improved distribution through digital tracking, and public-private partnerships enhancing ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

HealthSecretary Robert F. Kennedy Jr. has defunded research in messenger RNA vaccines, which could jeopardize efforts to ...

Het Hooggerechtshof had eerder geoordeeld dat een van Moderna’s patenten met betrekking tot messenger RNA (mRNA)-technologie ...

What makes this doubly frustrating is that Kennedy and his back-to-the-past approach to public health would be better off ...

The director of the National Institutes of Health, Jay Bhattacharya, explained why the federal government wound up $500 ...

Canceling federal mRNA vaccine projects threatens much more than pandemic response, an expert at Michigan State University ...

A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...